185 related articles for article (PubMed ID: 2868645)
1. Comparison of the efficacy and safety of esmolol, a short-acting beta blocker, with placebo in the treatment of supraventricular tachyarrhythmias. The Esmolol vs Placebo Multicenter Study Group.
Anderson S; Blanski L; Byrd RC; Das G; Engler R; Laddu A; Lee R; Rajfer S; Schroeder J; Steck JD
Am Heart J; 1986 Jan; 111(1):42-8. PubMed ID: 2868645
[TBL] [Abstract][Full Text] [Related]
2. Clinical experience with esmolol, a short-acting beta-adrenergic blocker in cardiac arrhythmias and myocardial ischemia.
Sung RJ; Blanski L; Kirshenbaum J; MacCosbe P; Turlapaty P; Laddu AR
J Clin Pharmacol; 1986 Mar; 26(S1):A15-A26. PubMed ID: 2870082
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of esmolol vs propranolol in the treatment of supraventricular tachyarrhythmias: a multicenter double-blind clinical trial.
Abrams J; Allen J; Allin D; Anderson J; Anderson S; Blanski L; Chadda K; DiBianco R; Favrot L; Gonzalez J
Am Heart J; 1985 Nov; 110(5):913-22. PubMed ID: 3904379
[TBL] [Abstract][Full Text] [Related]
4. Esmolol: a new ultrashort-acting beta-adrenergic blocking agent for rapid control of heart rate in postoperative supraventricular tachyarrhythmias.
Gray RJ; Bateman TM; Czer LS; Conklin CM; Matloff JM
J Am Coll Cardiol; 1985 Jun; 5(6):1451-6. PubMed ID: 2860148
[TBL] [Abstract][Full Text] [Related]
5. Intravenous esmolol for the treatment of supraventricular tachyarrhythmia: results of a multicenter, baseline-controlled safety and efficacy study in 160 patients. The Esmolol Research Group.
Am Heart J; 1986 Sep; 112(3):498-505. PubMed ID: 2875641
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy and tolerance of esmolol to propranolol for control of supraventricular tachyarrhythmia.
Morganroth J; Horowitz LN; Anderson J; Turlapaty P
Am J Cardiol; 1985 Oct; 56(11):33F-39F. PubMed ID: 2864847
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of esmolol (ASL-8052: an ultrashort-acting beta-adrenergic blocking agent) for control of ventricular rate in supraventricular tachycardias.
Byrd RC; Sung RJ; Marks J; Parmley WW
J Am Coll Cardiol; 1984 Feb; 3(2 Pt 1):394-9. PubMed ID: 6141193
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of esmolol in the treatment and transfer of patients with supraventricular tachyarrhythmias to alternate oral antiarrhythmic agents.
Das G; Tschida V; Gray R; Dhurandhar R; Lester R; McGrew F; Askenazi J; Kaplan K; Emanuele M; Turlapaty P
J Clin Pharmacol; 1988 Aug; 28(8):746-50. PubMed ID: 2905710
[TBL] [Abstract][Full Text] [Related]
9. Esmolol hydrochloride: an ultrashort-acting, beta-adrenergic blocking agent.
Angaran DM; Schultz NJ; Tschida VH
Clin Pharm; 1986 Apr; 5(4):288-303. PubMed ID: 2871961
[TBL] [Abstract][Full Text] [Related]
10. Clinical rationale for the use of an ultra-short acting beta-blocker: esmolol.
Barbier GH; Shettigar UR; Appunn DO
Int J Clin Pharmacol Ther; 1995 Apr; 33(4):212-8. PubMed ID: 7620691
[TBL] [Abstract][Full Text] [Related]
11. A new dosing regimen for esmolol to treat supraventricular tachyarrhythmia in Chinese patients.
Ko WJ; Chu SH
J Am Coll Cardiol; 1994 Feb; 23(2):302-6. PubMed ID: 7905013
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and antiarrhythmic effects of esmolol in children.
Trippel DL; Wiest DB; Gillette PC
J Pediatr; 1991 Jul; 119(1 Pt 1):142-7. PubMed ID: 1676729
[TBL] [Abstract][Full Text] [Related]
13. Use of esmolol during anesthesia to treat tachycardia and hypertension.
Gold MI; Sacks DJ; Grosnoff DB; Herrington C; Skillman CA
Anesth Analg; 1989 Feb; 68(2):101-4. PubMed ID: 2563314
[TBL] [Abstract][Full Text] [Related]
14. Effects of esmolol on airway function in patients with asthma.
Sheppard D; DiStefano S; Byrd RC; Eschenbacher WL; Bell V; Steck J; Laddu A
J Clin Pharmacol; 1986 Mar; 26(3):169-74. PubMed ID: 2870080
[TBL] [Abstract][Full Text] [Related]
15. Esmolol: a titratable short-acting intravenous beta blocker for acute critical care settings.
Turlapaty P; Laddu A; Murthy VS; Singh B; Lee R
Am Heart J; 1987 Oct; 114(4 Pt 1):866-85. PubMed ID: 2889341
[TBL] [Abstract][Full Text] [Related]
16. Esmolol in the treatment of supraventricular tachyarrhythmias.
Das G; Ferris J
Can J Cardiol; 1988 May; 4(4):177-80. PubMed ID: 2899451
[TBL] [Abstract][Full Text] [Related]
17. Managing critically ill patients with esmolol. An ultra short-acting beta-adrenergic blocker.
Gray RJ
Chest; 1988 Feb; 93(2):398-403. PubMed ID: 2892647
[TBL] [Abstract][Full Text] [Related]
18. Beta-adrenergic blockade accelerates conversion of postoperative supraventricular tachyarrhythmias.
Balser JR; Martinez EA; Winters BD; Perdue PW; Clarke AW; Huang W; Tomaselli GF; Dorman T; Campbell K; Lipsett P; Breslow MJ; Rosenfeld BA
Anesthesiology; 1998 Nov; 89(5):1052-9. PubMed ID: 9821992
[TBL] [Abstract][Full Text] [Related]
19. Esmolol for treatment of intraoperative tachycardia and/or hypertension in patients having cardiac operations. Bolus loading technique.
Reves JG; Croughwell ND; Hawkins E; Smith LR; Jacobs JR; Rankin S; Lowe J; VanTrigt P
J Thorac Cardiovasc Surg; 1990 Aug; 100(2):221-7. PubMed ID: 1974664
[TBL] [Abstract][Full Text] [Related]
20. Safety of esmolol in patients with acute myocardial infarction treated with thrombolytic therapy who had relative contraindications to beta-blocker therapy.
Mooss AN; Hilleman DE; Mohiuddin SM; Hunter CB
Ann Pharmacother; 1994 Jun; 28(6):701-3. PubMed ID: 7919552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]